VAV3 mediates resistance to breast cancer endocrine therapy.

MLA

Aguilar, Helena, et al. “VAV3 Mediates Resistance to Breast Cancer Endocrine Therapy.” Breast Cancer Research : BCR, vol. 16, no. 3, May 2014, p. R53. EBSCOhost, https://doi.org/10.1186/bcr3664.

APA

Aguilar, H., Urruticoechea, A., Halonen, P., Kiyotani, K., Mushiroda, T., Barril, X., Serra-Musach, J., Islam, A., Caizzi, L., Di Croce, L., Nevedomskaya, E., Zwart, W., Bostner, J., Karlsson, E., Pérez Tenorio, G., Fornander, T., Sgroi, D. C., Garcia-Mata, R., Jansen, M. P. H. M., … Pujana, M. A. (2014). VAV3 mediates resistance to breast cancer endocrine therapy. Breast Cancer Research : BCR, 16(3), R53. https://doi.org/10.1186/bcr3664

Chicago

Aguilar, Helena, Ander Urruticoechea, Pasi Halonen, Kazuma Kiyotani, Taisei Mushiroda, Xavier Barril, Jordi Serra-Musach, et al. 2014. “VAV3 Mediates Resistance to Breast Cancer Endocrine Therapy.” Breast Cancer Research : BCR 16 (3): R53. doi:10.1186/bcr3664.